You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205001 - 205010 of 207725 results
  1. Production of Fumaric Acid From Corn by Fermentation

    SBC: General Resource Technology, Inc.            Topic: N/A

    There are three specific objectives. Once attained, the technology will be ready for pilot plant tests, with commercializatin to follow. 1. The mold that produces fumaric acid from glucose has a tendency to form large pellets. When that happens, oxygen shortage will develop in the pellet center that will make the cells to produce ethanol instead of fumaric acid. An objective is to further test tec ...

    SBIR Phase I 2002 Department of Agriculture
  2. Production of Glycerol from Corn by a Yeast Fermentation

    SBC: General Resource Technology, Inc.            Topic: N/A

    This Phase II proposal and the recently completed Phase I project deal with a new process of production of glycerol from cornstarch by a yeast fermentation. There are two current industrial processes for glycerol. Chemical syntheses are no longer competitive. The second method involves recovering glycerol as a byproduct from soap and other fatty acid industries. It suffers from the decline of the ...

    SBIR Phase I 2001 Department of Agriculture
  3. Ordnance Research; Thermobaric HTI for Defeat of BW/CW

    SBC: GENERAL SCIENCES INC            Topic: N/A

    The proposed SBIR Phase II effort will build upon the demonstration success of the Phase I effort for the reduction of viable Biological Warfare (BW) agent (stimulant) release from a scaled target structure, concurrent with denial of the use of the BWagent remaining within the target structure to minimize collateral damage potential form the engagement of a threat BW storage facility. The Phase I ...

    SBIR Phase I 2001 Department of DefenseAir Force
  4. Lethality Enhancement by Hi-Therm Reactive Materials

    SBC: GENERAL SCIENCES INC            Topic: N/A

    "The Phase I effort produced very important and encouraging results in terms of interceptor lethality enhancement. This was achieved by the innovative development and testing of high density reactive composites which as projectiles or impacting structurescan deliver large amounts of chemical energy to the target in addition to kinetic, in a non-parasitic manner. This effort proved that (a) these ...

    SBIR Phase I 2002 Department of DefenseMissile Defense Agency
  5. Enhanced DNA microarray performance with patterned probe

    SBC: GENESPECTRUM            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of the proposed research is to develop a method for significantly improving the performance of sequencing by hybridization (SBH), thus decreasing the cost and increasing the speed of sequencing DNA. If successful, the technology that GeneSpectrum Inc. is developing will reduce the cost of such sequencing by 100 fold. The limitations of current DNA sequ ...

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. N/A

    SBC: GENETICA, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  7. A GENETIC APPROACH TO DRUG FUNCTION

    SBC: GENETICA, INC.            Topic: N/A

    DESCRIPTION (Adapted from the investigator's abstract): The development of new drugs is an expensive process that requires extensive testing of a drug's mechanism of action and safety. Although many compounds are designed for the ability to exert a desired biological effect, few perform satisfactorily as drugs due to unexpected modes of action in vivo. The investi ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  8. A SYSTEMATIC APPROACH TO EARLY DIAGNOSIS OF CANCER

    SBC: GENETICA, INC.            Topic: N/A

    Prostate cancer is the second leading cause of cancer death in men, killing approximately 32,000 men annually. An urgent need exists for improved diagnostic and prognostic tools. PSA tests are widely used diagnostic tools, but they yield an unacceptable degree of false positives and false negatives. Due to a lack of prognostic tools, many men undergo unnecessary, radical treatments. We describe he ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. STABLE SUPPRESSION OF GENE FUNCTION IN MAMMALS BY RNAI

    SBC: GENETICA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cultured mammalian cells are the most commonly used model organisms, both in academic and in industrial biology. However, the tools that are available for manipulating these cells have been relatively primative compared to those available in other model organisms, such as C. elegans and Drosophila. It has been the primary missio ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. N/A

    SBC: GENETRACE SYSTEMS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government